Table 1.
Demographics and vaccination status of HCW in relation to the results of RADT at day 7 post diagnosis.
| Total | Positive | Negative | p-value | |
|---|---|---|---|---|
| Age | ||||
| Mean±SD | 37.5 ± 8.7 | 37.5 ± 8.7 | 37.6 ± 8.8 | 0.878 |
| < 35 | 193 (40.4%) | 71 (36.8%) | 122 (63.2%) | 0.948 |
| 35–44 | 182 (38.1%) | 64 (35.2%) | 118 (64.8%) | |
| ≥ 45 | 103 (21.5%) | 37 (35.9%) | 66 (64.1%) | |
| Gender | ||||
| Male | 176 (36.7%) | 69 (39.2%) | 107 (60.8%) | 0.252 |
| Female | 303 (63.3%) | 103 (34.0%) | 200 (66.0%) | |
| Profession | ||||
| Nurse | 192 (40.0%) | 59 (30.7%) | 133 (69.3%) | 0.048 |
| Physician | 75 (15.6%) | 33 (44.0%) | 42 (56.0%) | 0.118 |
| Others | 213 (44.4%) | 81 (38.0%) | 132 (62.0%) | 0.418 |
| Unit | ||||
| ICU | 36 (7.5%) | 11 (30.6%) | 25 (69.4%) | 0.476 |
| ER | 54 (11.3%) | 21 (38.9%) | 33 (61.1%) | 0.644 |
| Laboratory/radiology/pharmacy | 67 (14.0%) | 30 (44.8%) | 37 (55.2%) | 0.108 |
| Respiratory therapy | 18 (3.8%) | 7 (38.9%) | 11 (61.1%) | 0.798 |
| OR | 25 (5.2%) | 6 (24.0%) | 19 (76.0%) | 0.198 |
| Wards | 178 (37.1%) | 63 (35.4%) | 115 (64.6%) | 0.820 |
| Outpatient | 50 (10.4%) | 17 (34.0%) | 33 (66.0%) | 0.751 |
| Non-clinical | 52 (10.8%) | 18 (34.6%) | 34 (65.4%) | 0.821 |
| Vaccination status | ||||
| Two doses | 358 (75.1%) | 123 (34.4%) | 235 (65.6%) | 0.239 |
| Three doses | 119 (24.9%) | 48 (40.3%) | 71 (59.7%) | |
| Duration in days related to vaccine (mean SD) | ||||
| Between dose 1 and dose 2 | 98.2 ± 46.4 | 93.9 ± 45.7 | 100.6 ± 46.7 | 0.353 |
| Between dose 2 and dose 3 | 200.0 ± 54.2 | 203.8 ± 60.3 | 197.6 ± 50.1 | 0.474 |
| Between dose 1 and dose 3 | 293.9 ± 40.4 | 295.5 ± 42.5 | 292.8 ± 39.2 | 0.537 |
| Duration in days between last vaccine dose and COVID-19 infection (mean SD) | 52.5 ± 78.8 | 48.8 ± 79.8 | 54.6 ± 78.4 | 0.298 |